This medical technology stock is back in a buy zone and nearing its all-time high.

A newly published Perspective article in Nature Nanotechnology details groundbreaking nanoparticle technology to eliminate ...

Kyowa Kirin will file for rocatinlimab’s US approval, which was once Amgen’s most late-stage pipeline candidate.

ATLANTA — Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving treatments to market, drug companies say. Traditionally, developing ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The pharmaceutical industry faces the challenge of balancing innovation with affordability.

A Rexburg-based sales team is promoting a new saliva drug test that they say is faster, easier to watch in real time, and ...

KELOWNA, BC / ACCESS Newswire / September 19, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to ...

A team has developed a large-scale drug screening technique that can track target molecule behavior within cells. The researchers verified their technique by testing the epidermal growth factor ...

Lisata Therapeutics and GATC Health Corp have initiated a strategic partnership that aims to enhance the drug discovery and development process using GATC's advanced AI-powered Multiomics Advanced ...

In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...

CHENGDU, China--(BUSINESS WIRE)--HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the ...